Atossa Genetics Inc (ATOS) Financials

$2.40

$-0.12 (-4.57%)

As on 09-Sep-2026 16:00EDT

Market cap

$25 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.01	0.02	0.02	0.02	0.01	0.02
Gross Profit	-0.01	-0.02	-0.02	-0.02	-0.01	-0.02
Operating Expenses	39.24	37.14	27.62	31.38	27.69	20.52
Operating Profit (EBIT)	-39.25	-37.14	-27.62	-31.38	-27.69	-20.52
Other Income	--	--	--	--	0.73	-0.09
Profit before Tax	-37.71	-34.77	-25.50	-30.09	-26.96	-20.61
Provision for Tax	--	--	--	--	-0.73	-0.21
Profit after Tax (Net Income)	-37.71	-34.77	-25.50	-30.09	-26.23	-20.61
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-26.96	-20.61

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	26.83	39.35	71.48	91.02	117.96	138.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	0.00	0.00
Current Liabilities	5.45	8.26	4.97	5.24	5.57	3.13
Total Liabilities	37.73	47.61	76.44	96.25	123.53	141.26

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.27	1.99	1.99	4.03	5.34	0.02
Current Assets	31.01	45.62	74.46	92.22	118.20	141.24
Total Assets	37.73	47.61	76.44	96.25	123.53	141.26
Total Debt*	--	--	--	--	--	--
Net Current Assets	25.56	37.36	69.49	86.98	112.63	138.11

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-29.76	-21.03	-20.94	-20.76	-16.47
Cash Flow from Investing Activities	--	-0.02	-0.02	-0.01	-4.73	-0.01
Cash from Financing Activities	--	--	3.67	-1.48	0.00	113.30
Net Cash Inflow / Outflow	--	--	--	--	-25.49	96.82

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-4.34	-4.04	-3.02	-0.24	-3.11	-2.44
Cash EPS ($)	--	-4.04	-3.02	-0.24	-3.11	-2.44
Adjusted Book Value ($)	--	4.57	8.47	0.73	13.97	16.37
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-3.46	-2.49	-0.17	-2.46	-1.95
Free Cash Flow per Share ($)	--	-3.46	-2.49	-0.17	-2.46	-1.95

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-62.74	-31.39	-28.80	-20.48	-24.93
ROE (%)	-113.95	-62.74	-31.39	-28.80	-20.48	-24.93
ROA (%)	-69.15	-56.06	-29.54	-27.39	-19.81	-22.39
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-3,588.10	24,242.35
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-31.31	-36.33	15.25	-8.68	-34.38	-41.07
Net Profit Growth (%)	-31.31	-36.33	15.25	-14.74	-27.29	-15.58
EPS Growth (%)	-28.83	-0.34	-11.58	0.92	-0.27	0.15
Book Value Growth (%)	-55.05	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.15	-0.31	-3.66	-0.17	-0.66
Price / Book Value	0.90	0.13	0.11	1.21	0.04	0.10
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.01	1.04	2.48	-0.73	3.84	5.97
Close Price ($)	1.93	8.85	14.16	13.20	7.93	24.00
High Price ($)	19.35	19.35	34.65	20.85	27.00	147.00
Low Price ($)	1.70	8.27	11.62	7.50	7.50	13.13
Market Cap ($ Cr)	25.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	5.69	5.53	14.99	17.61	21.23	45.18
Quick Ratio	5.69	--	--	17.33	20.29	44.35
Interest Coverage	--	--	--	--	-3,461.38	-242.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	31,948.63	53,469.42	179,086.64	35,904.88
Payable days	--	56,750.72	15,952.83	29,942.56	106,881.28	26,247.29
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.